Variables

Univariate

Multivariate

Hazard Ratio (95% CI) p-value

Hazard Ratio (95% CI) p-value

Age ≥ 65 y (vs. <65 y)

1.248 (0.849 - 1.834)

0.259

Male gender (Y/N)

0.897 (0.611 - 1.318)

0.581

MPO-ANCA (vs. PR3-ANCA)

1.155 (0.583 - 2.286)

0.679

General manifestation (Y/N)

0.796 (0.537 - 1.182)

0.258

ENT involvement (Y/N)

0.628 (0.199 - 1.979)

0.427

Cardiovascular involvement (Y/N)

2.575 (1.757 - 3.774)

<0.001

1.174 (0.783 - 1.760)

0.438

Abdominal involvement (Y/N)

3.291 (2.241 - 4.833)

<0.001

1.415 (0.910 - 2.199)

0.123

Nervous system involvement (Y/N)

1.214 (0.692 - 2.131)

0.499

Pulmonary involvement (Y/N)

1.284 (0.877 - 1.881)

0.199

ILD (Y/N)

1.126 (0.746 - 1.700)

0.571

Hematuria or Proteinuria

1.894 (1.127 - 3.183)

0.016

1.027 (0.596 - 1.770)

0.922

Alveolar hemorrhage

1.492 (0.917 - 2.427)

0.107

SCR ≥ 500 μmol/L (vs. <500 μmol/L)

20.935 (12.266 - 35.732)

<0.001

13.583 (7.646 - 24.128)

<0.001

C3 ≤ 0.8 g/L (vs. >0.8 g/L)

1.769 (1.193 - 2.625)

0.005

1.506 (1.001 - 2.264)

0.049

Hemoglobin ≤ 90 g/L (vs. >90 g/L)

2.836 (1.882 - 4.274)

<0.001

1.090 (0.698 - 1.701)

0.705

ALB < 30 g/L (vs. ≥30 g/L)

1.070 (0.729 - 1.570)

0.731

BVAS ≥ 15 (vs. <15)

3.577 (2.391 - 5.351)

<0.001

1.660 (1.083 - 2.543)

0.020

Immunosuppressive treatment (Y/N)

0.314 (0.211 - 0.467)

<0.001

0.523 (0.340 - 0.803)

0.003